Unitas Pharmaceuticals Private Limited
Manufacturer of GMP certified healthcare products including tablets, capsules, syrups, and more.
1994 | Central Delhi, Delhi (India) | Active
Unitas Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
- Paid Up Capital ₹ 5.21 M
- Company Age 31 Year, 28 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.13 Cr
- Satisfied Charges ₹ 1.00 M
- Revenue Growth -3.00%
- Profit Growth 180.07%
- Ebitda -9.59%
- Net Worth 126.54%
- Total Assets 1.95%
About Unitas Pharmaceuticals
Unitas Pharmaceuticals Private Limited (UPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 02 March 1994 and has a history of 31 years. Its registered office is in Central Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 5.21 M.
The company currently has active open charges totaling ₹5.13 Cr. The company has closed loans amounting to ₹1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Neelam Nijhawan and Akhilesh Nagar serve as directors at the Company.
Company Details
- Location
Central Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74899DL1994PTC057671
- Company No.
057671
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Mar 1994
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Who are the key members and board of directors at Unitas Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neelam Nijhawan  | Director | 14-Jan-2001 | Current |
| Akhilesh Nagar | Director | 02-Mar-1994 | Current |
Financial Performance of Unitas Pharmaceuticals.
Unitas Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3% decrease. The company also saw a substantial improvement in profitability, with a 180.07% increase in profit. The company's net worth Soared by an impressive increase of 126.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unitas Pharmaceuticals?
Unlock access to Unitas Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Unitas Life Sciences Private Limited
Akhilesh Nagar is a mutual person
Charges (Loans)
Open Charges
₹51.30 M
Satisfied Charges
₹1.00 M
Charges Breakdown by Lending Institutions
- Others : 2.74 Cr
- State Bank Of India : 2.15 Cr
- Hdfc Bank Limited : 0.24 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 May 2023 | Hdfc Bank Limited | ₹2.43 M | Open |
| 30 Jul 2013 | Others | ₹2.74 Cr | Open |
| 02 Apr 2003 | State Bank Of India | ₹2.15 Cr | Open |
| 28 Sep 1999 | Bank Of India | ₹0.25 M | Satisfied |
| 28 Sep 1999 | Bank Of India | ₹0.75 M | Satisfied |
How Many Employees Work at Unitas Pharmaceuticals?
Unlock and access historical data on people associated with Unitas Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unitas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unitas Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Unitas Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Unitas Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
- Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.43 M with Charge ID 100755689 was registered on 24 May 2023.
- Balance Sheet
Unitas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
- Charges
A charge with Others of Rs. 27.37 M registered on 30 Jul 2013 with Charge ID 10450560 was modified on 07 Aug 2020.
- Charges
A charge with Others amounted to Rs. 27.37 M with Charge ID 10450560 was registered on 30 Jul 2013.
- Charges
A charge with State Bank Of India of Rs. 21.50 M registered on 02 Apr 2003 with Charge ID 90058088 was modified on 26 Mar 2011.
Frequently asked questions
What is the Incorporation or founding date of Unitas Pharmaceuticals Private Limited?
Unitas Pharmaceuticals Private Limited was incorporated on 02 Mar 1994.
What is authorized share capital and paid-up capital of Unitas Pharmaceuticals Private Limited?
The authorized share capital of Unitas Pharmaceuticals Private Limited is ₹ 6.00 M and paid-up capital is ₹ 5.21 M.
Who are the current board members & directors of Unitas Pharmaceuticals Private Limited?
Currently 2 directors are associated with Unitas Pharmaceuticals Private Limited.
- Neelam Nijhawan
- Akhilesh Chander Nagar
What is the registered address of Unitas Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Unitas Pharmaceuticals Private Limited is R-28, Inderpuri India, New Delhi, 110012.
What is the corporate identification number (CIN) and company number of Unitas Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Unitas Pharmaceuticals Private Limited is U74899DL1994PTC057671 and the company number is 057671 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Unitas Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Unitas Pharmaceuticals Private Limited has fallen by -3.00%.
What change has been observed in the net worth of Unitas Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Unitas Pharmaceuticals Private Limited has experienced an upsurge of 126.54%.
What are the total open charges for Unitas Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Unitas Pharmaceuticals Private Limited amount to ₹ 5.13 Cr.
When was the last Balance Sheet of Unitas Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Unitas Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.